Jazz Pharmaceuticals (JAZZ) Goodwill (2010 - 2026)

Jazz Pharmaceuticals' Goodwill history runs 17 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Goodwill rose 2.55% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 2.55% YoY), while the FY2025 annual figure was $1.8 billion, up 6.58% from the prior year.
• Goodwill for Q1 2026 stood at $1.8 billion, down from $1.8 billion in the prior quarter.
• The five-year high for Goodwill was $1.8 billion in Q2 2025, with the low at $1.6 billion in Q3 2022.
• The 5-year median for Goodwill is $1.7 billion (2023), against an average of $1.7 billion.
• Peak annual rise in Goodwill reached 89.95% in 2022, while the deepest fall reached 13.89% in 2022.
• Jazz Pharmaceuticals' Goodwill stood at $1.7 billion in 2022, then rose by 3.57% to $1.8 billion in 2023, then fell by 2.1% to $1.7 billion in 2024, then increased by 6.58% to $1.8 billion in 2025, then fell by 1.33% to $1.8 billion in 2026.
• Business Quant data shows JAZZ's Goodwill at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.